Monsanto (company)

Monsanto (company)
Name	Monsanto
Type	Public
Industry	Agrochemical
Fate	Acquired by Bayer (2018)
Founded	1901
Founder	John Francis Queeny
Headquarters	St. Louis, Missouri, United States
Products	Herbicides; Seeds; Genetically modified organisms
Revenue	See Corporate Structure and Financials

Monsanto (company) was an American agrochemical and agricultural biotechnology corporation founded in 1901 by John Francis Queeny in St. Louis, Missouri. The firm became prominent for products including PCBs, Agent Orange components, the herbicide glyphosate marketed as Roundup, and genetically modified seeds such as Roundup Ready crops and Bt corn. Over the twentieth and twenty‑first centuries Monsanto intersected with institutions like DuPont, Bayer, Syngenta, and regulatory bodies including the United States Environmental Protection Agency and courts such as the United States Supreme Court.

History

Monsanto began in 1901 when John Francis Queeny founded a chemical company in St. Louis, Missouri supplying coca‑cola bottlers and later expanded into saccharin production, linking to the broader industrial networks of American Sugar Refining Company and H. J. Heinz Company. In the 1920s and 1930s Monsanto diversified into polychlorinated biphenyls production, later sold globally and associated with regulatory actions by the United States Environmental Protection Agency and litigation in the United States District Court system. During World War II and the Vietnam War era Monsanto produced components used in Agent Orange, tying the company to military procurement by the United States Department of Defense and subsequent claims adjudicated before tribunals such as the United States Court of Appeals for the Federal Circuit. In the 1970s and 1980s Monsanto expanded into agricultural science through acquisitions and research collaborations with institutions like Massachusetts Institute of Technology spin‑offs and firms including Calgene and DeKalb Genetics Corporation. The 1990s and 2000s saw Monsanto pioneer recombinant DNA traits in crops, launching Bt corn, Roundup Ready soybeans and partnering with Cargill, Bunge Limited, and Archer Daniels Midland Company in commodity markets. Corporate milestones involved listings on the New York Stock Exchange, leadership transitions with CEOs such as Hugh Grant (businessman) and Robert Shapiro (businessman), and scrutiny from regulatory agencies including the United States Department of Justice and the European Commission.

Products and Technologies

Monsanto’s portfolio included chemical products such as PCBs and industrial chemicals supplied to firms like General Electric and Dow Chemical Company, and agricultural inputs including the herbicide glyphosate branded as Roundup sold through retail networks like Home Depot and Lowe's Companies, Inc.. The company developed genetically modified traits such as Roundup Ready herbicide tolerance and Bt (Bacillus thuringiensis) insect resistance implemented in crops including soybean, maize, cotton, and canola through seed businesses interfacing with firms like John Deere and Monsanto Technology LLC. Monsanto pursued biotechnology research with collaborations at universities including University of Missouri and Iowa State University and maintained intellectual property via United States Patent and Trademark Office filings and litigation in jurisdictions including the European Union and Brazil. Related services encompassed seed breeding, trait licensing to companies such as Bayer CropScience prior to acquisition talks, and digital agriculture initiatives later integrated into networks with Climate Corporation and PrecisionHawk.

Controversies and Legal Issues

Monsanto was central to numerous disputes involving product liability, environmental contamination, and intellectual property. Litigation over PCBs involved suits against industrial defendants in New York (state) and settlements administered through United States District Courts. Agent Orange‑related claims implicated veterans and families in tribunals including the United States Court of Appeals for the Federal Circuit and led to settlement frameworks coordinated with the Department of Veterans Affairs. Cases concerning Roundup and alleged links to non‑Hodgkin lymphoma produced verdicts in state courts such as in California and appeals heard by the United States Court of Appeals for the Ninth Circuit and the Supreme Court of California. Intellectual property disputes over patented seeds invoked patent litigation before the United States Court of Appeals for the Federal Circuit and enforcement actions against farmers in Iowa, Argentina, and India, involving entities like Vandana Shiva and organizations such as Via Campesina. Regulatory controversies included disputes with the European Food Safety Authority and the European Commission over approval of genetically modified organisms and herbicide residues.

Environmental and Health Impact

Scientific and regulatory assessments of Monsanto products engaged agencies such as the World Health Organization, International Agency for Research on Cancer, and the United States Environmental Protection Agency. Debates over glyphosate classification by the International Agency for Research on Cancer and re‑evaluations by the European Chemicals Agency and the United States Environmental Protection Agency generated policy disputes involving lawmakers in United States Congress hearings and governmental reviews in Brazil and Argentina. Environmental impacts of genetically modified crops touched on biodiversity concerns raised by conservation groups such as Greenpeace and Friends of the Earth and studies published in journals accessed by researchers at National Institutes of Health and the Rockefeller University. Soil, water, and pollinator effects prompted regulatory action in jurisdictions including France and Germany and litigation concerning contamination and ecological risk assessments.

Corporate Structure and Financials

Monsanto operated as a publicly traded company listed on the New York Stock Exchange with investor relations tied to institutions like Goldman Sachs and Morgan Stanley. Financial reporting adhered to filings with the United States Securities and Exchange Commission and oversight by auditors such as the Big Four (auditing firms), reflecting revenues from seed sales, trait licensing, and agrochemical distribution through channels including Bayer CropScience partnerships and commodity traders like Louis Dreyfus Company. Leadership changes involved corporate officers and boards with members from conglomerates like Dow Chemical Company, and shareholder actions sometimes engaged activist investors represented by firms like Elliott Management Corporation. The company's financial position and liabilities were key considerations in merger negotiations and antitrust reviews by the European Commission and the United States Department of Justice.

Mergers and Acquisition (Sale to Bayer)

In 2016 Bayer announced a proposed acquisition of Monsanto, a transaction reviewed by the European Commission, the United States Department of Justice, and antitrust authorities in countries including Brazil and China. The sale, completed in 2018 after divestitures to companies such as BASF and Corteva Agriscience to address competition concerns, resulted in integration of Monsanto assets into Bayer AG and ensuing legal and regulatory consequences handled through courts like the United States Court of Appeals for the Ninth Circuit and arbitration forums under rules referenced by International Chamber of Commerce.

Category:Agricultural companies of the United States Category:Biotechnology companies Category:Defunct companies based in Missouri